Activity

  • Ewing Upton posted an update 6 years, 3 months ago

    0.?40.21.41.22.42.23.43.24. 25. 26.44.45.27. 28.?46.47.29.30.48.31.49.32.50.?33.34.?51.35.52.Curr Osteoporos Rep (2015) 13:140?45 prostate cancer patients with bone metastases. J Manag Care Pharm. 2011;17:621?3. 53. Gartrell BA, Coleman RE, Fizazi K, et al. Toxicities following remedy with bisphosphonates and receptor activator of nuclear factor-kappaB ligand inhibitors in patients with sophisticated prostate cancer. Eur Urol. 2014;65:278?six. 54. Allen MR, Burr DB. The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: countless hypotheses, so couple of data. J Oral Maxillofac Surg. 2009;67:61?0. 55. Khan A, Morrison A, Hanley D, et al. Diagnosis and management of osteonecrosis with the jaw: a systematic review and international consensus. J Bone Miner Res. 2014. Significant systematic critique discussing osteonecrosis in the jaw just after treatment with antiresorptive agents. 56.145 Demeestere I, Brice P, Peccatori FA, et al. Gonadotropin-releasing hormone agonist for j.addbeh.2012.ten.012 the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial. J Clin Oncol. 2013;31:903?. 57. Yang B, Shi W, Yang J, et al. Concurrent remedy with gonadotropin-releasing hormone agonists for chemotherapyinduced ovarian damage in premenopausal females with breast cancer: a meta-analysis of randomized controlled trials. Breast. 2013;22:150?. 58. Song G, Gao H, Yuan Z. Effect of leuprolide acetate on ovarian function right after cyclophosphamide-doxorubicin-based chemotherapy in premenopausal individuals with breast cancer: benefits from a phase II randomized trial. Med Oncol. 2013;30:667.Safety and Safety The paradigm of new technologies as social experiments (henceforth NTaSE) offers with accountable deployment of technologies that might have undesirable side-effects. The concept is that it truly is impossible to determine all possible challenges within the design stage, and that it may as a result be necessary to subject society to a deployment experiment with uncertain outcomes. As a result far, the uncertain outcomes addressed in the NTaSE-paradigm have been largely safety-related (nuclear waste and accidents, overall health effects of nanoparticles, genetically modified crops and so forth.). Safety implies that possible harm is brought on by the design plus accidental events inside the environment, which include purchase Pemafibrate all-natural disasters and human jir.2012.0142 mistakes. What the paradigm has not covered so far are so-called adversarial risks. They are risks which are not brought on by probabilistic all-natural events or accidents, even human failures, but rather by the determined, strategic behaviour of an adversarial agent. This is usually labelled safety as opposed to security. Essentially the most apparent instance within the NTaSE literature of a technologies having a safety component is nuclear technologies: adversaries who get hold of nuclear material might use it for weapons. Lately, Lehtveer and Hedenus (2015) discussed this extensively in terms of nuclear proliferation. Exactly where the NTaSE-literature has discussed nuclear technology, it has focused on accidents (security), and has not addressed this adversarial viewpoint (safety). By way of example, Krohn and Weingart (1987) explicitly concentrate on the “accident as implicit experiment”, analysing the Chernobyl Meltdown, and inside the exact same vein, Van de Poel (2011) analyses the Fukushima accident.